triparanol has been researched along with ouabain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
| Gruber, L; Harris, JE | 1 |
2 other study(ies) available for triparanol and ouabain
| Article | Year |
|---|---|
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |
Reversal of triparanol-induced cataracts in the rat. II. Exchange of 22 Na, 42 K, and 86 Rb in cataractous and clearing lenses.
Topics: Animals; Biological Transport, Active; Cataract; Cell Membrane Permeability; Lens, Crystalline; Ouabain; Potassium; Potassium Isotopes; Rats; Rubidium; Sodium; Sodium Isotopes; Triparanol | 1972 |